Your browser is no longer supported. Please, upgrade your browser.
HomeNewsScreenerMapsGroupsPortfolioInsiderFuturesForexCryptoBacktestsElite Help
publish chart | save to portfolio | create alert Type: candle | line | advanced | interactive | perf    Timeframe: intraday | daily | weekly | monthly  Settings
NVAX [NASD]
Novavax, Inc.
Healthcare | Biotechnology | USA
statements
Index- P/E- EPS (ttm)-9.25 Insider Own0.20% Shs Outstand74.09M Perf Week8.89%
Market Cap15.55B Forward P/E5.78 EPS next Y35.19 Insider Trans-61.13% Shs Float73.34M Perf Month5.72%
Income-615.10M PEG- EPS next Q-3.63 Inst Own59.40% Short Float8.29% Perf Quarter-2.10%
Sales919.50M P/S16.91 EPS this Y-32.00% Inst Trans2.10% Short Ratio1.43 Perf Half Y60.06%
Book/sh14.23 P/B14.28 EPS next Y648.10% ROA-40.60% Target Price271.75 Perf Year45.60%
Cash/sh26.11 P/C7.78 EPS next 5Y0.00% ROE-125.70% 52W Range76.59 - 331.68 Perf YTD82.26%
Dividend- P/FCF27.03 EPS past 5Y9.50% ROI-38.00% 52W High-38.72% Beta1.62
Dividend %- Quick Ratio1.90 Sales past 5Y67.30% Gross Margin- 52W Low165.36% ATR15.07
Employees791 Current Ratio1.90 Sales Q/Q13143.40% Oper. Margin-65.50% RSI (14)54.97 Volatility11.38% 7.59%
OptionableYes Debt/Eq0.44 EPS Q/Q-423.70% Profit Margin-66.90% Rel Volume0.82 Prev Close209.89
ShortableYes LT Debt/Eq0.33 EarningsAug 05 AMC Payout- Avg Volume4.25M Price203.24
Recom2.00 SMA202.54% SMA5013.06% SMA20022.62% Volume3,496,971 Change-3.17%
May-12-21Downgrade JP Morgan Overweight → Neutral $285 → $161
Dec-14-20Initiated Jefferies Buy $200
Aug-06-20Reiterated H.C. Wainwright Buy $132 → $290
Aug-05-20Upgrade JP Morgan Neutral → Overweight $275
Aug-05-20Downgrade Ladenburg Thalmann Neutral → Sell $105
Jul-16-20Reiterated H.C. Wainwright Buy $101 → $132
Jul-08-20Downgrade Ladenburg Thalmann Buy → Neutral $50 → $105
Jun-29-20Reiterated H.C. Wainwright Buy $50 → $101
Jun-29-20Reiterated B. Riley FBR Buy $74 → $106
Jun-05-20Upgrade JP Morgan Underweight → Neutral $46
May-28-20Reiterated B. Riley FBR Buy $53 → $61
May-12-20Reiterated H.C. Wainwright Buy $33 → $50
Apr-30-20Reiterated H.C. Wainwright Buy $24 → $33
Nov-27-19Resumed B. Riley FBR Buy $12
Aug-14-19Reiterated H.C. Wainwright Buy $10 → $17
Feb-28-19Downgrade Piper Jaffray Overweight → Underweight $4.50 → $0.25
Dec-18-18Initiated Ladenburg Thalmann Buy $3
Dec-11-18Initiated Oppenheimer Outperform $4
Nov-26-18Upgrade Piper Jaffray Neutral → Overweight
Sep-21-18Upgrade JP Morgan Underweight → Overweight
Jul-25-21 06:06AM  
It's Game Over for Dogecoin, but These Stocks Can Still Go to the Moon
Motley Fool
05:52AM  
3 Red-Hot Stocks That Are Still Dirt Cheap
Motley Fool
Jul-24-21 06:19AM  
Do Earnings Reports Matter for Biotech Stocks?
Motley Fool
Jul-23-21 01:53PM  
Doctor on the Olympics regarding COVID-19: There are a lot of concerns
Yahoo Finance Video
06:02AM  
Why BioNTech, Moderna, and Novavax Stocks Soared This Week
Motley Fool
Jul-22-21 02:36PM  
We havent seen the high consequence variants yet: Doctor
Yahoo Finance Video
02:26PM  
Is Novavax Stock A Buy Or Sell As It Trails Covid Vaccine Leaders Pfizer, Moderna?
Investor's Business Daily
09:20AM  
10 Best One Dollar Stocks to Buy Now
Insider Monkey
Jul-21-21 01:43PM  
Its very premature to talk about booster vaccines: Doctor
Yahoo Finance Video
Jul-20-21 05:45PM  
Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know
Zacks
02:51PM  
Likelihood of reaching herd immunity at this point is fairly low: Epidemiologist
Yahoo Finance Video
Jul-19-21 03:12PM  
Why Coronavirus Stocks Are Zooming Higher Today
Motley Fool +12.78%
02:01PM  
Vaccination is really our route out of this pandemic: Doctor
Yahoo Finance Video
12:29PM  
Covid-19 Opportunity Still at Play for Novavax, Says Top Analyst
TipRanks
Jul-16-21 02:46PM  
Moderna surges, Square to enter DeFi space, Intel in talks to buy GlobalFoundries
Yahoo Finance Video
01:37PM  
We need to continue mask wearing even with vaccination: Doctor
Yahoo Finance Video
06:00AM  
3 Things About Novavax That Smart Investors Know
Motley Fool
Jul-15-21 05:50PM  
Novavax (NVAX) Gains As Market Dips: What You Should Know
Zacks
02:58PM  
Coronavirus vaccines are a miracle of science: Doctor
Yahoo Finance Video
Jul-14-21 01:49PM  
Pockets of the U.S. seeing potential for a 4th COVID-19 wave: Doctor
Yahoo Finance Video
09:11AM  
15 Best Penny Stocks to Buy Now
Insider Monkey
06:10AM  
Why Novavax Stock Soared 90% in the First Half of 2021
Motley Fool
Jul-13-21 05:06AM  
COVID-19 Vaccines: How Much Revenue Will Each Drugmaker Generate in 2021?
Motley Fool
Jul-12-21 03:09PM  
If vaccinated you are very protected against all the variants that we have right now: Doctor
Yahoo Finance Video
01:22PM  
Is Novavax Stock A Buy On The Effectiveness Of Its Coronavirus Vaccine?
Investor's Business Daily
Jul-11-21 06:06AM  
These Stocks Will See Sales More Than Double in 2022, According to Wall Street
Motley Fool
Jul-09-21 05:45PM  
Novavax (NVAX) Stock Sinks As Market Gains: What You Should Know
Zacks
02:22PM  
Doctor: I would discourage getting booster shot different from the vaccine you received
Yahoo Finance Video
05:55AM  
Why Novavax Stock Dropped This Week
Motley Fool
Jul-08-21 01:57PM  
Doctor: If you are unvaccinated you are at risk
Yahoo Finance Video
11:48AM  
Why Moderna and Novavax Stocks Are Jumping Today
Motley Fool
06:51AM  
Vaccine Stocks Fall as Delta Becomes Dominant Variant in US
Zacks
Jul-07-21 09:16PM  
Why Novavax Was Up 44% in June
Motley Fool -13.67%
04:06PM  
Vaccine Stocks Moderna, Novavax Crumble Under Weight Of Delta Variant
Investor's Business Daily
01:46PM  
People will start to get sick and die again if we dont get vaccinated: Doctor
Yahoo Finance Video
Jul-06-21 02:21PM  
Doctor on COVID-19 recovery: We cant let down our guard
Yahoo Finance Video
08:30AM  
Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021
PR Newswire
Jul-02-21 05:45PM  
Novavax (NVAX) Gains But Lags Market: What You Should Know
Zacks
03:38PM  
Why Johnson & Johnsons vaccine update is welcome news
Yahoo Finance Video
01:39PM  
Without global control of the pandemic were going to see new variants: Doctor
Yahoo Finance Video
06:30AM  
This is Novavax's Biggest Challenge Right Now
Motley Fool
06:06AM  
3 Value Stocks That'll Make You Richer in July (and Beyond)
Motley Fool
06:00AM  
Can Novavax Beat Moderna and Pfizer in Preventing Severe COVID?
Motley Fool
02:36AM  
UPDATE 2-Novavax says Taiwan has opted to get firm's COVID-19 vaccine via COVAX
Reuters
Jul-01-21 09:03PM  
Novavax says Taiwan has opted to get firm's COVID vaccine via COVAX
Reuters
02:10PM  
Delta variant of COVID-19 creates surges in Europe and Asia, as Euro 2020 soccer tournament sparks outbreak
MarketWatch
10:00AM  
How High Can Novavax's Shares Go?
Motley Fool
09:04AM  
Novavax's experimental COVID-19 shot has 86.4% efficacy against the Alpha variant
MarketWatch
09:03AM  
Vaccine Makers Stocks Are Moving as Also-Rans Fight for Spots in the Market
Barrons.com
09:00AM  
Here's What May Drive Novavax Shares Higher
Motley Fool
08:30AM  
This Is Novavax's Biggest Opportunity Right Now
Motley Fool
07:29AM  
Novavax COVID Vaccine Candidate Shows 86.3% Efficacy Vs. Alpha Variant
TheStreet.com
06:05AM  
How Big of a Splash Might Novavax Make in the COVID Vaccine Market?
Motley Fool
Jun-30-21 05:50PM  
Novavax (NVAX) Outpaces Stock Market Gains: What You Should Know
Zacks
05:26PM  
Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine
PR Newswire
02:39PM  
Quidel CEO on the Delta variant impacting the need for COVID-19 testing
Yahoo Finance Video
02:20PM  
Going out without a mask is quite safe for those fully vaccinated: Doctor
Yahoo Finance Video
01:42PM  
15 Best Medical Stocks to Invest In
Insider Monkey
12:21PM  
Why Novavax Stock Is Rising Today
Motley Fool
06:09AM  
Is Novavax the Leader in Developing a Combo COVID/Flu Vaccine?
Motley Fool
Jun-28-21 02:09PM  
Delta variant is getting people in the public health world nervous: Doctor
Yahoo Finance Video
09:05AM  
Hedge Funds Have Never Been This Bullish On Novavax, Inc. (NVAX)
Insider Monkey
08:06AM  
The Covid-19 Booster Market Just Keeps Getting Bigger, Modernas CEO Says
Barrons.com
Jun-27-21 05:51AM  
These Are 5 of the Fastest-Growing Large-Cap Stocks on the Planet
Motley Fool
Jun-26-21 06:03AM  
Here's Why Novavax's Solid Vaccine Data Didn't Move the Stock
Motley Fool
06:00AM  
Is Novavax Stock a Buy?
Motley Fool
12:00AM  
Is Novavax's COVID-19 Vaccine Superior to the mRNA Vaccines?
Motley Fool
Jun-25-21 06:00PM  
Why Has Novavax Stock Been Jumping Higher?
Motley Fool
03:18PM  
Its concerning seeing variants popping up all over the world: Doctor
Yahoo Finance Video
Jun-24-21 05:45PM  
Novavax (NVAX) Gains But Lags Market: What You Should Know
Zacks
05:04PM  
Why COVID Vaccine Stocks Moderna, Novavax, and BioNTech Soared This Week
Motley Fool
02:00PM  
Unchecked spread in the U.S. is going to lead to other problems: Doctor
Yahoo Finance Video
01:29PM  
A Covid underclass is forming
Yahoo Finance Video
Jun-23-21 05:50PM  
Novavax (NVAX) Dips More Than Broader Markets: What You Should Know
Zacks
01:48PM  
Vaccination is very effective against the Delta variant: Doctor
Yahoo Finance Video
Jun-22-21 06:38PM  
Novavax Posted Great Vaccine Data. Heres Whats Next
TipRanks +7.39%
05:52AM  
Why Moderna Just Booked Another $3 Billion in Vaccine Orders and No One Cared
Motley Fool
Jun-21-21 02:44PM  
Delta COVID-19 variant likely to become dominant U.S. strain: Doctor
Yahoo Finance Video
Jun-20-21 07:31AM  
Is Now the Time to Go All-In On Novavax Stock?
Motley Fool
Jun-19-21 07:00AM  
A Biotech Pro Exited Novavax Stock. Here Are Three Stocks It Bought.
Barrons.com
06:06AM  
Got $10,000? Here Are Summer's Hottest Stocks to Buy
Motley Fool
Jun-18-21 02:04PM  
Gov. Duceys decision to block COVID-19 policies for universities is not based in science: Doctor
Yahoo Finance Video
06:00AM  
How Does Novavax Stack Up Against Today's Vaccine Leaders?
Motley Fool
05:47AM  
Why BioNTech, Moderna, and Novavax Stocks Sank This Week
Motley Fool
Jun-17-21 04:02PM  
Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum
PR Newswire
03:07PM  
Affordable Care Act survives third Supreme Court challenge
Yahoo Finance Video
10:28AM  
2 Stocks That Are Running Circles Around Bitcoin This Year
Motley Fool
10:19AM  
Pfizer Covid-19 Vaccine Could See Blockbuster Sales for Years
Barrons.com
09:22AM  
Novavax to Participate in National Vaccine Advisory Committee Meeting
PR Newswire
08:05AM  
Dow Jones Futures Fall On Fed Rate-Hike Losses; Goldman In Buy Range, Covid Vaccine Play CureVac Crashes
Investor's Business Daily
07:15AM  
Raw Material Shortage Holding Up Novavax's COVID-19 Shot Manufacturing, Says Serum Institute
Benzinga
06:00AM  
Influencers with Andy Serwer: David Ricks
Yahoo Finance Video
06:00AM  
By next summer we'll have enough vaccines to vaccinate the world: Eli Lilly CEO
Yahoo Finance Video
Jun-16-21 07:31PM  
CureVac Started the Day Worth More Than Novavax. Then Its Vaccine News Hit.
Barrons.com -5.79%
02:34PM  
Biotech Stock Roundup: SAGE Declines on Data, Regulatory Updates From VRTX, ITOS
Zacks
01:48PM  
COVID-19 pandemic is far from over in other parts of the world: Doctor
Yahoo Finance Video
10:20AM  
Biogens FDA Win Marks a Mini-Rally in Biotech Stocks
Barrons.com
09:57AM  
FDA shifting the bar for approval with new Alzheimers drug: Eli Lilly CEO
Yahoo Finance Video
Jun-15-21 03:20PM  
Workers sue over mandatory COVID-19 vaccination
Yahoo Finance Video -9.94%
02:38PM  
Fear grows that delta variant will become dominant COVID strain worldwide as WHO says its now in 74 countries
MarketWatch
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical trial; and ResVax, a respiratory syncytial virus (RSV) fusion (F) protein nanoparticle vaccine candidate. It is also developing RSV F vaccine that is in Phase II clinical trial for older adults (60 years and older), as well as that is in Phase I clinical trial for pediatrics. In addition, the company develops vaccine candidates for the protection against middle east respiratory syndrome, as well as that is in preclinical work associated with severe acute respiratory syndrome; and ebola virus glycoprotein vaccine candidate, as well as COVID-19 vaccine for variant strain. It has a collaboration agreement with Takeda Pharmaceutical Company Limited for the development, manufacturing, and commercialization of NVX-CoV2373, a COVID-19 vaccine candidate. Novavax, Inc. was incorporated in 1987 and is headquartered in Gaithersburg, Maryland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Glenn Gregory MPresident, R&DJul 20Sale215.432,409518,9822,811Jul 22 05:20 PM
Glenn Gregory MPresident, R&DJul 15Option Exercise13.0810,477137,0068,465Jul 19 07:52 PM
Glenn Gregory MPresident, R&DJul 15Sale179.455,6541,014,5972,811Jul 19 07:52 PM
Erck Stanley CPresident and CEOJul 02Option Exercise80.6652,5594,239,51173,054Jul 06 05:03 PM
Erck Stanley CPresident and CEOJul 02Sale215.8952,55911,347,06620,495Jul 06 05:03 PM
Erck Stanley CPresident and CEOJul 01Option Exercise61.5952,6203,240,96573,115Jul 06 05:03 PM
Erck Stanley CPresident and CEOJul 01Sale212.8852,62011,201,51320,495Jul 06 05:03 PM
Glenn Gregory MPresident, R&DJun 17Sale183.282,411441,8872,811Jun 17 06:17 PM
Glenn Gregory MPresident, R&DJun 15Option Exercise13.1610,535138,6858,527Jun 17 06:17 PM
Glenn Gregory MPresident, R&DJun 15Sale191.425,7161,094,1302,811Jun 17 06:17 PM
EVANS GARY CDirectorJun 01Sale146.5062591,5620Jun 03 05:34 PM
Herrmann John A IIIEVP, Chief Legal OfficerMay 28Option Exercise14.832,89542,9323,170Jun 02 04:59 PM
Herrmann John A IIIEVP, Chief Legal OfficerMay 28Sale149.142,895431,748275Jun 02 04:59 PM
King Rachel K.DirectorMay 19Buy139.6470097,7482,800May 21 05:06 PM
Glenn Gregory MPresident, R&DMay 19Sale142.172,385339,0662,811May 19 05:26 PM
Glenn Gregory MPresident, R&DMay 17Option Exercise13.1610,531138,5778,523May 19 05:26 PM
Glenn Gregory MPresident, R&DMay 17Sale133.985,712765,2672,811May 19 05:26 PM
Trizzino JohnEVP, CCO, CBO & Interim CFOMay 07Sale176.6319033,559287May 07 05:10 PM
Trizzino JohnEVP, CCO, CBO & Interim CFOMay 05Option Exercise14.733,40650,1603,309May 07 05:10 PM
Trizzino JohnEVP, CCO, CBO & Interim CFOMay 05Sale185.463,022560,471287May 07 05:10 PM
Herrmann John A IIIEVP, Chief Legal OfficerApr 30Option Exercise14.822,89542,8923,170May 04 06:03 PM
Herrmann John A IIIEVP, Chief Legal OfficerApr 30Sale239.832,895694,317275May 04 06:03 PM
Trizzino JohnEVP, Chief Commercial OfficerApr 07Sale178.0319134,004287Apr 07 05:09 PM
Trizzino JohnEVP, Chief Commercial OfficerApr 05Option Exercise34.013,404115,7713,308Apr 07 05:09 PM
Trizzino JohnEVP, Chief Commercial OfficerApr 05Sale190.103,021574,292287Apr 07 05:09 PM
Herrmann John A IIIEVP, Chief Legal OfficerMar 26Option Exercise14.822,89442,8863,169Mar 30 06:10 PM
Herrmann John A IIIEVP, Chief Legal OfficerMar 26Sale186.802,894540,609275Mar 30 06:10 PM
YOUNG JAMES FDirectorMar 25Option Exercise8.9647,500425,43857,500Mar 25 06:41 PM
YOUNG JAMES FDirectorMar 23Option Exercise46.0010,000460,00020,000Mar 25 06:41 PM
YOUNG JAMES FDirectorMar 23Sale228.2210,0002,282,23110,000Mar 25 06:41 PM
MCMANUS MICHAEL A JRDirectorMar 19Sale220.784,000883,1105,951Mar 23 05:33 PM
Glenn Gregory MPresident, R&DMar 17Sale218.862,423530,3042,811Mar 17 06:35 PM
EVANS GARY CDirectorMar 15Option Exercise19.5224,500478,33040,599Mar 17 06:36 PM
Glenn Gregory MPresident, R&DMar 15Option Exercise109.9510,5311,157,8438,523Mar 17 06:35 PM
Glenn Gregory MPresident, R&DMar 15Sale198.605,7121,134,4002,811Mar 17 06:35 PM
EVANS GARY CDirectorMar 15Sale211.2124,5005,174,53616,099Mar 17 06:36 PM
Trizzino JohnEVP, Chief Commercial OfficerMar 09Sale168.0919031,937287Mar 09 07:38 PM
Trizzino JohnEVP, Chief Commercial OfficerMar 05Option Exercise14.733,40450,1483,308Mar 09 07:38 PM
Trizzino JohnEVP, Chief Commercial OfficerMar 05Sale163.463,021493,824287Mar 09 07:38 PM
Herrmann John A IIIEVP, Chief Legal OfficerFeb 26Option Exercise14.822,89542,8923,170Mar 02 05:37 PM
Herrmann John A IIIEVP, Chief Legal OfficerFeb 26Sale225.482,895652,759275Mar 02 05:37 PM
Glenn Gregory MPresident, R&DFeb 18Sale269.572,434656,1342,811Feb 18 06:59 PM
Glenn Gregory MPresident, R&DFeb 16Option Exercise13.1610,531138,5778,523Feb 18 06:55 PM
Glenn Gregory MPresident, R&DFeb 16Sale282.715,7121,614,8122,811Feb 18 06:55 PM
Trizzino JohnEVP, Chief Commercial OfficerFeb 09Sale324.5019462,953287Feb 09 07:40 PM
Trizzino JohnEVP, Chief Commercial OfficerFeb 05Option Exercise14.733,40650,1603,309Feb 09 07:40 PM
Trizzino JohnEVP, Chief Commercial OfficerFeb 05Sale290.463,022877,766287Feb 09 07:40 PM
Herrmann John A IIIEVP, Chief Legal OfficerFeb 01Option Exercise18.1515,022272,72415,297Feb 03 05:37 PM
Herrmann John A IIIEVP, Chief Legal OfficerFeb 01Sale241.5015,0223,627,789275Feb 03 05:37 PM
Trizzino JohnEVP, CMO and CBOJan 07Sale124.1750662,830287Jan 07 07:08 PM
Trizzino JohnEVP, CMO and CBOJan 05Option Exercise18.6313,756256,24317,694Jan 07 07:08 PM
Trizzino JohnEVP, CMO and CBOJan 05Sale112.0017,4071,949,522287Jan 07 07:08 PM
YOUNG JAMES FDirectorDec 31Option Exercise51.2711,000564,00011,000Jan 05 05:38 PM
DOUGLAS RICHARDDirectorDec 31Option Exercise50.001,00050,00028,500Jan 05 05:42 PM
YOUNG JAMES FDirectorDec 31Sale113.0911,0001,244,0140Jan 05 05:38 PM
Erck Stanley CPresident and CEONov 16Option Exercise37.1452,3171,942,80172,811Nov 18 06:09 PM
Erck Stanley CPresident and CEONov 16Sale90.6552,3164,742,66720,495Nov 18 06:09 PM
Erck Stanley CPresident and CEOOct 01Sale108.56221720,494Oct 01 05:39 PM
Trizzino JohnEVP, CBO and CFOSep 30Sale110.222,250248,0025,087Oct 01 05:40 PM
Erck Stanley CPresident and CEOSep 30Sale110.2312,2311,348,20020,496Oct 01 05:39 PM
Herrmann John A IIIEVP, Chief Legal OfficerSep 29Sale107.3118,0291,934,667275Sep 30 09:30 PM
Trizzino JohnEVP, CBO and CFOSep 29Sale107.2918,3211,965,6307,337Sep 30 09:28 PM
Glenn Gregory MPresident, R&DSep 29Sale107.0219,9492,134,8441,561Sep 30 09:29 PM
Erck Stanley CPresident and CEOSep 29Sale107.804,112443,26732,727Sep 30 09:27 PM
Trizzino JohnEVP, CBO and CFOSep 28Option Exercise5.9529,600176,12053,008Sep 30 09:28 PM
Erck Stanley CPresident and CEOSep 28Option Exercise5.9550,000297,50074,606Sep 30 09:27 PM
Herrmann John A IIIEVP, Chief Legal OfficerSep 28Option Exercise5.9524,750147,26243,054Sep 30 09:30 PM
Glenn Gregory MPresident, R&DSep 28Option Exercise5.9525,000148,75046,510Sep 30 09:29 PM
Herrmann John A IIIEVP, Chief Legal OfficerSep 28Sale110.3024,7502,729,87918,304Sep 30 09:30 PM
Glenn Gregory MPresident, R&DSep 28Sale110.3025,0002,757,45621,510Sep 30 09:29 PM
Trizzino JohnEVP, CBO and CFOSep 28Sale110.3025,0002,757,45625,658Sep 30 09:28 PM
Erck Stanley CPresident and CEOSep 28Sale110.3025,0002,757,45636,839Sep 30 09:27 PM
EVANS GARY CDirectorAug 18Option Exercise31.0210,500325,700332,479Aug 20 06:09 PM
Glenn Gregory MPresident, R&DAug 18Option Exercise33.5655,9211,876,52557,760Aug 20 06:14 PM
Herrmann John A IIIEVP, Chief Legal OfficerAug 18Option Exercise53.8246,2422,488,61346,517Aug 20 06:20 PM
MCMANUS MICHAEL A JRDirectorAug 18Option Exercise27.608,000220,80017,951Aug 20 06:22 PM
Trizzino JohnEVP, CBO and CFOAug 18Option Exercise50.9542,7882,179,98647,875Aug 20 06:25 PM
Trizzino JohnEVP, CBO and CFOAug 18Sale148.7842,7886,366,1825,087Aug 20 06:25 PM
MCMANUS MICHAEL A JRDirectorAug 18Sale146.008,0001,168,0009,951Aug 20 06:22 PM
Herrmann John A IIIEVP, Chief Legal OfficerAug 18Sale144.3346,2426,673,982275Aug 20 06:20 PM
Glenn Gregory MPresident, R&DAug 18Sale145.2055,9218,119,8601,839Aug 20 06:14 PM
EVANS GARY CDirectorAug 18Sale150.4410,5001,579,620321,979Aug 20 06:09 PM
open in yahoo | open in reuters | open in marketwatch | open in google
affiliate • advertise • contact • privacy • help
Do not sell my personal information
Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2021 FINVIZ.com. All Rights Reserved.